Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Stereotactic Body Radiotherapy (SBRT) Following Radical Prostatectomy

NCT03541850 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT03541850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03541850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Stereotactic Body Radiotherapy (SBRT) Following Radical Prostatectomy
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 29, 2019
Completion date
November 1, 2027
Enrollment
92 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

psa level greater than 0.03, psa progression, stage i prostate adenocarcinoma ajcc (american joint committee on cancer ) v7, stage ii prostate adenocarcinoma ajcc v7, stage iii prostate adenocarcinoma ajcc v7